From URS to PQ: Laser Drilling Validation Path with Part 11 Readiness

Introduction

As regulators tighten data integrity requirements, validation of laser drilling systems must ensure complete traceability from design intent to operational performance. Parameters, inspection images, and rejection logs must be captured consistently across URS → FRS → DQ/IQ/OQ/PQ, in line with FDA 21 CFR Part 11 expectations.

1. Common Challenges in Validation

• Incomplete documentation loop: URS does not align with final delivery, causing audit gaps in design traceability.
• Non-compliant electronic records: Missing user permissions, audit trails, or electronic signatures; unclear backup/retention strategy.
• Opaque interfaces: MES/ERP integration fields not clearly defined, leading to repeated validation cycles.
• Insufficient training: Lack of deviation handling, change control, and re-validation trigger criteria.

2. HUANGHAI’s Validation & Compliance Support

• Documentation: Validation documentation templates are provided; on-site validation is carried out by the end user.
• Part 11: Designed to support 21 CFR Part 11 compliance (audit trail, electronic records, access control).
• Interface: Batch management with an MES/ERP interface.
• Training: Operator training is part of the solution.

3. Summary

Include data and system interfaces in your validation plan from the start. Use a risk-based approach to define test depth.

🔗 Related Product: Olando K3-2 Pharmaceutical Laser Drilling System

---

Frequently Asked Questions

Q: How does laser drilling create controlled-release tablets?

A: Laser drilling creates a precise aperture in the tablet coating, forming the drug delivery orifice for osmotic pump tablet systems (OROS technology). The osmotic pressure differential between the tablet core and gastrointestinal fluids drives API release through this aperture at a controlled rate. Hole diameter, depth (blind vs. through-hole), and position are critical parameters. The Olando K3-2 offers ±0.1 mm accuracy and up to 120,000 tablets/hour (based on a 15 mm tablet), with closed-loop vision inspection.

Q: Can the Olando K3-2 drill blind holes and through-holes?

A: Yes — the Olando K3-2 offers 0.9 mm blind/through-hole precision with ±0.05 mm hole depth consistency.

Q: What tablet shapes and sizes can the Olando K3-2 process?

A: The Olando K3-2 handles bilayer round tablets. Supported tablet diameters range from 6 mm to 20 mm. The system processes up to 120,000 tablets/hour (based on a 15 mm tablet).

Q: Is the laser drilling system designed to support FDA 21 CFR Part 11 requirements?

A: The Olando K3-2 Laser Drilling System is designed for cGMP environments, uses a Siemens PLC, and is designed to support 21 CFR Part 11 compliance (audit trail, electronic records, access control). For a full Part 11 workflow (final compliance is established by the end user's own validation), integrate the system's data outputs into a validated manufacturing execution system (MES). Reference customers include Shanghai Modern Pharmaceutical (12 installed units for Nifedipine CR) and Shanghai Xinyi Pharmaceutical (3 units for Doxazosin Mesylate).

Q: What are the ongoing maintenance requirements for laser drilling equipment?

A: Key maintenance items for the Olando K3-2: Preventive maintenance should be incorporated into your equipment qualification protocol (IQ/OQ/PQ).